Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by PinkyndthaBrainon Jan 20, 2018 12:50pm

294 Views

Post# 27400976

RE:RE:RE:RE:RE:FAKE NEWS

i would like to add where i read that they are entering the canadian market, that is whats going to bring most of the revenue in short term, until businesses become more stable in america, but in the long run revenue in the states will surpass the canadian, more cities will follow california with legalization like they did 20 years ago when california banned smoking in restaurants the rest followed, soon we will have the best of both worlds

Bullboard Posts

Dollar Tree CEO Rick Dreiling steps down as discount retailer struggles